Literature DB >> 17136637

[IGF-I, VEGF and bFGF as predictive factors for the onset of retinopathy of prematurity (ROP)].

E Villegas-Becerril1, R González-Fernández, L Perula-Torres, J M Gallardo-Galera.   

Abstract

OBJECTIVE: To determine if IGF-I, VEGF and bFGF, present in the serum of premature infants, are independent risk factors of the development of ROP. It was also our objective to design a multivariate model that included these three cytokines as indicator parameters in the ROP screening, in addition to the other parameters already in existence.
METHODS: 74 patients were recruited with a birth weight below 1500g or gestational age below 32 weeks. These were classified into those who developed ROP (N = 37) and those without ROP (N = 37). We obtained serum from each infant at the time of the first examination at 4-6 postnatal weeks. These samples were frozen until the time of analysis. The roles of gestational age and birth weight were also evaluated.
RESULTS: There were significant differences in the amount of the cytokines IGF-I and VEGF between the groups with or without ROP, but there were no significant differences for bFGF. The differences enabled us to establish a multivariate model including IGF-I and VEGF for the prediction of risk of ROP.
CONCLUSIONS: Cytokine serum levels in premature infants can be useful as an indicator in ROP screening, as well as being used to predict the probability of suffering the illness.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17136637     DOI: 10.4321/s0365-66912006001100005

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  9 in total

Review 1.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 2.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

Review 3.  Bioactive lipids and pathological retinal angiogenesis.

Authors:  Khaled Elmasry; Ahmed S Ibrahim; Samer Abdulmoneim; Mohamed Al-Shabrawey
Journal:  Br J Pharmacol       Date:  2018-11-19       Impact factor: 8.739

4.  POSTNATAL SERUM INSULIN-LIKE GROWTH FACTOR I AND RETINOPATHY OF PREMATURITY.

Authors:  Anne K Jensen; Gui-Shuang Ying; Jiayan Huang; Graham E Quinn; Gil Binenbaum
Journal:  Retina       Date:  2017-05       Impact factor: 4.256

5.  Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity.

Authors:  Raul Velez-Montoya; Carmen Clapp; Jose Carlos Rivera; Gerardo Garcia-Aguirre; Virgilio Morales-Cantón; Jans Fromow-Guerra; Jose Luis Guerrero-Naranjo; Hugo Quiroz-Mercado
Journal:  Clin Ophthalmol       Date:  2010-09-07

Review 6.  Algorithms for the prediction of retinopathy of prematurity based on postnatal weight gain.

Authors:  Gil Binenbaum
Journal:  Clin Perinatol       Date:  2013-06       Impact factor: 3.430

7.  Up-regulated basigin-2 in microglia induced by hypoxia promotes retinal angiogenesis.

Authors:  Jie Yin; Wen-Qin Xu; Ming-Xiang Ye; Yong Zhang; Hai-Yan Wang; Jian Zhang; Yu Li; Yu-Sheng Wang
Journal:  J Cell Mol Med       Date:  2017-06-29       Impact factor: 5.310

8.  Correlation between apelin and VEGF levels in retinopathy of prematurity: a matched case-control study.

Authors:  Yimin Zhang; Jing Feng; Shuming Shao; Qing Mu; Jie Liu; Chaomei Zeng; Xiaorui Zhang
Journal:  BMC Ophthalmol       Date:  2022-08-11       Impact factor: 2.086

9.  Insulin-like growth factor binding protein-3 in preterm infants with retinopathy of prematurity.

Authors:  Manizheh Mostafa Gharehbaghi; Ali Peirovifar; Karim Sadeghi; Haleh Mostafidi
Journal:  Indian J Ophthalmol       Date:  2012 Nov-Dec       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.